Arnold & Porter Receives Six Awards at the 11th Annual LMG Life Sciences Americas Awards

Arnold & Porter’s life sciences legal work was recognized six times at the 11th annual LMG Life Sciences Americas Awards on September 7, 2023. In addition to being honored with two “Firm of the Year” designations, the firm also received three individual awards, and the firm’s work in Amgen v. Sanofi was named a “Patent Impact Case of the Year.”

The firm was recognized in the following areas:

• General Patent Litigator of the Year – DC Metro: Matthew Wolf
• Government Investigations Attorney of the Year: Michael Rogoff
• Life Cycle Firm of the Year – United States
• Patent Impact Case of Year – United States: Amgen v Sanofi (U.S. Supreme Ct 2023)
• Regulatory Attorney of the Year: Pricing & Reimbursement: Jeffrey Handwerker
• Regulatory Firm of the Year

Arnold & Porter was recognized as "US Life Cycle Firm of the Year" for its excellence in the key areas LMG Life Sciences recognizes, including antitrust, intellectual property, regulatory, financial, and corporate, and non-IP litigation and enforcement. The firm also was named “Regulatory Firm of the Year” for its high-profile and cutting-edge work for PhRMA, advising major pharmaceutical companies on price reporting matters, and guidance on anti-kickback compliance issues related to the structuring of specialty pharmacy arrangements.

LMG Life Sciences honored Intellectual Property practice co-chair Matthew Wolf for the third time as “General Patent Litigator of the Year – DC Metro” following his United States Supreme Court victory on behalf of clients, Sanofi-Aventis US and Regeneron Pharmaceuticals Inc., which was also recognized at the ceremony as a “Patent Impact Case of the Year.” In Amgen v. Sanofi, the Supreme Court upheld the Federal Circuit’s application of the enablement requirement and unanimously affirmed Arnold & Porter’s successful invalidation of Amgen’s patents. For Hologic, Wolf secured a complete plaintiff and counter-claim defense jury verdict for Hologic and affirmance on appeal, and the Supreme Court upheld the assignor estoppel doctrine.

Michael Rogoff, co-chair of the firm’s False Claims Act Investigations & Defense practice, was named “Government Investigations Attorney of the Year” in recognition of his outstanding qui tam work for clients Eli Lilly & Co., Bayer, and AbbVie. He has successfully guided clients through government investigations in the life sciences industry for more than two decades.

Life Sciences & Healthcare Regulatory partner Jeffrey Handwerker was recognized for the third time as “Regulatory Attorney of the Year: Pricing & Reimbursement” due to his work representing AstraZeneca in a landmark decision related to the Administrative Procedure Act and his invaluable advisory work with multiple, major pharmaceutical companies.

From Left to Right: Arnold & Porter partners Betty Yan, Dan Kracov, Jeffrey Handwerker, Michael Rogoff, and Carmela Romeo